Bengaluru-based medical technology startup SigTuple has secured an undisclosed amount of seed funding from a group of investors which include Flipkart founders Sachin and Binny Bansal and Accel Partners (via ET).
Other angel investors include Nirupa Bareja, former Biocon executive and an experienced professional in Biotech and Pharma industry; Ashok Bareja who is the former India head of the now-defunct National Semiconductor; and Amazon Lab126 executive Debanjan Mukherjee.
SigTuple was founded last year by former AmEx Big Data Labs executives Tathagato Rai Dastidar, Rohit Kumar Pandey and Apurv Anand. The startup aims to make medical diagnostic procedure efficient and fast by analysing blood samples with the help of technology.
Our aim is to build affordable solutions for automating disease diagnosis. A single pathologist can review analysis reports from multiple collection centers through our web-based interface, without the physical samples having to be shipped to a central testing facility,
said Dastidar and Pandey.
They further added that such kind of healthcare tech can prove immensely useful in a country like India where people have to sometimes travel long distances to see a doctor or getting a simple blood test.
The company claims to use artificial intelligence and machine learning in its solutions for accurate analysis of blood samples and minimizing human errors.
The company’s flagship product called Shonit can automatically analyse images of blood captured through a microscope. The product is in advanced stages of development and comprises a microscope, a cellphone app and a cloud-powered engine for analysis and reporting.
Shonit is able to detect various diseases like anaemia, malaria, leukaemia and other diseases. The company is now trying to develop a similar diagnosis system for dengue.
On his investment in SigTuple, Sachin Bansal said,
I strongly believe that artificial intelligence is going to change the way healthcare delivery works today. It will play a big role in improving the efficiency, accuracy and outreach of medical services.
Accel Partners, which are currently also supporting SigTuple at their incubation centre in Bengaluru, admitted making a seed investment along with other well-known angels but refused to divulge any further details.
The company is really early in its search for product-market fit, and therefore, cannot provide more details at the time,
said Subrata Mitra, Partner at Accel Partners.